• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤靶细胞MHC I类分子对CR3(CD11b/CD18)依赖性自然杀伤(NK)细胞细胞毒性的调节作用。

Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.

作者信息

Vĕtvicka V, Hanikýrová M, Vĕtvicková J, Ross G D

机构信息

Division of Experimental Immunology and Immunopathology, Department of Pathology, University of Louisville, KY, USA.

出版信息

Clin Exp Immunol. 1999 Feb;115(2):229-35. doi: 10.1046/j.1365-2249.1999.00800.x.

DOI:10.1046/j.1365-2249.1999.00800.x
PMID:9933447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1905157/
Abstract

Phagocyte and NK cell CR3 functions as both an adhesion molecule and an iC3b receptor mediating cytotoxic responses to microorganisms. Cytotoxic activation of iC3b receptor function requires ligation of both a CD11b I-domain site for iC3b and a lectin site located in the C-terminus of CD11b. Because tumours lack the CR3-binding polysaccharides of bacteria and fungi, iC3b-opsonized tumours do not stimulate CR3-dependent cytotoxicity. Previous studies showed that NK cells could be induced to kill iC3b-opsonized tumours with small soluble beta-glucans that bound with high affinity to CR3, bypassing the absence of similar polysaccharides on tumour membranes. Because CR3 signalling requires several tyrosine phosphorylation events, it appeared possible that CR3-dependent killing of autologous tumour cells might be suppressed by NK cell inhibitory receptors for MHC class I (KIR and CD94/NKG2) whose action involves recruitment of SHP-1 and SHP-2 tyrosine phosphatases. In the current study, Epstein-Barr virus (EBV)-transformed B cells were used as targets following opsonization with iC3b. Soluble beta-glucan primed CR3 for killing of iC3b-coated B cells, but autologous class I-bearing targets were 84% more resistant than class I-deficient Daudi cells. Blockade of target cell class I with a MoAb specific for a domain recognized by both KIR and CD94/NKG2 resulted in comparable killing of class I+ B cells. By contrast, another MoAb to class II had no effect on cytotoxicity. These data suggest that NK cell recognition of class I suppresses CR3/tyrosine kinase-dependent cytotoxicity in the same way as it suppresses cytotoxicity mediated by other tyrosine kinase-linked receptors such as FcgammaRIIIA (CD16).

摘要

吞噬细胞和自然杀伤(NK)细胞的补体受体3(CR3)作为一种黏附分子和iC3b受体,介导对微生物的细胞毒性反应。iC3b受体功能的细胞毒性激活需要iC3b的CD11b I结构域位点和位于CD11b C末端的凝集素位点的连接。由于肿瘤缺乏细菌和真菌的CR3结合多糖,iC3b调理的肿瘤不会刺激CR3依赖性细胞毒性。先前的研究表明,NK细胞可以被小的可溶性β-葡聚糖诱导杀伤iC3b调理的肿瘤,这些β-葡聚糖与CR3具有高亲和力结合,绕过了肿瘤膜上缺乏类似多糖的情况。由于CR3信号传导需要几个酪氨酸磷酸化事件,因此CR3依赖性杀伤自体肿瘤细胞可能会被MHC I类NK细胞抑制性受体(KIR和CD94/NKG2)抑制,其作用涉及募集SHP-1和SHP-2酪氨酸磷酸酶。在当前的研究中,爱泼斯坦-巴尔病毒(EBV)转化的B细胞在用iC3b调理后用作靶细胞。可溶性β-葡聚糖引发CR3以杀伤iC3b包被的B细胞,但自体携带I类的靶细胞比I类缺陷的Daudi细胞耐药性高84%。用对KIR和CD94/NKG2都识别的结构域具有特异性的单克隆抗体阻断靶细胞I类,导致对I类+B细胞的杀伤相当。相比之下,另一种针对II类的单克隆抗体对细胞毒性没有影响。这些数据表明,NK细胞对I类的识别以与抑制其他酪氨酸激酶连接受体(如FcγRIIIA,CD16)介导的细胞毒性相同的方式抑制CR3/酪氨酸激酶依赖性细胞毒性。

相似文献

1
Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.肿瘤靶细胞MHC I类分子对CR3(CD11b/CD18)依赖性自然杀伤(NK)细胞细胞毒性的调节作用。
Clin Exp Immunol. 1999 Feb;115(2):229-35. doi: 10.1046/j.1365-2249.1999.00800.x.
2
Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.可溶性β-葡聚糖多糖与中性粒细胞或自然杀伤细胞补体3型受体(CD11b/CD18)的凝集素位点结合,会使该受体处于一种能够介导iC3b调理素化靶细胞细胞毒性的致敏状态。
J Clin Invest. 1996 Jul 1;98(1):50-61. doi: 10.1172/JCI118777.
3
The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.小鼠CR3(CD11b/CD18)的β-葡聚糖结合凝集素位点及其在使受体产生预激活状态中的功能,该受体介导对iC3b调理的靶细胞的细胞毒性激活。
J Immunol. 1999 Feb 15;162(4):2281-90.
4
Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.肝恶性肿瘤患者肝脏中表达MHC I类抑制性受体的自然杀伤细胞和T细胞的选择性减少。
Cancer Immunol Immunother. 2003 Jan;52(1):53-8. doi: 10.1007/s00262-002-0331-1. Epub 2002 Dec 10.
5
Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets.白细胞黏附分子(CD11a - c/CD18)在增强自然杀伤细胞对iC3b调理靶标的杀伤作用中的需求。
J Immunol. 1989 Jun 1;142(11):4100-4.
6
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.白细胞介素-15诱导人胸腺早期前体细胞自然杀伤细胞成熟:CD94/NKG2-A作为唯一的HLA I类特异性抑制性受体的选择性表达。
Eur J Immunol. 1997 Jun;27(6):1374-80. doi: 10.1002/eji.1830270612.
7
Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).通过天然存在的肿瘤细胞结合的iC3b和β-葡聚糖致敏的CR3(CD11b/CD18)将自然杀伤细胞靶向至乳腺癌
J Immunol. 1997 Jul 15;159(2):599-605.
8
Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.在一种自然杀伤样细胞系YTINDY中,p58.2或CD94/NKG2A抑制性受体的表达导致HLA I类分子介导的细胞毒性抑制,这种抑制作用在表达p58.2的转染细胞中存在,而在表达CD94/NKG2A的转染细胞中不存在。
Cell Immunol. 2002 Sep;219(1):57-70. doi: 10.1016/s0008-8749(02)00578-6.
9
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.抑制性自然杀伤细胞受体CD94/NKG2 - A和激活受体CD94/NKG2 - C与HLA - E结合的动力学及肽依赖性
EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250.
10
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.人类白细胞抗原E(HLA-E)与自然杀伤细胞受体CD94/NKG2A、B及C相结合。
Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869.

引用本文的文献

1
Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.优化肿瘤微环境用于癌症免疫治疗:β-葡聚糖纳米粒子。
Front Immunol. 2018 Feb 26;9:341. doi: 10.3389/fimmu.2018.00341. eCollection 2018.
2
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.C1q在Her2/neu驱动的乳腺癌发生过程中的非炎症作用。
Oncoimmunology. 2016 Nov 8;5(12):e1253653. doi: 10.1080/2162402X.2016.1253653. eCollection 2016.
3
Neutrophil Integrins and Matrix Ligands and NET Release.中性粒细胞整合素与基质配体及中性粒细胞胞外陷阱释放
Front Immunol. 2016 Sep 19;7:363. doi: 10.3389/fimmu.2016.00363. eCollection 2016.
4
Reactivity of the immunological system of rats stimulated with Biolex-Beta HP after cyclophosphamide immunosuppression.环磷酰胺免疫抑制后用Biolex-Beta HP刺激的大鼠免疫系统的反应性。
Cent Eur J Immunol. 2014;39(1):51-60. doi: 10.5114/ceji.2014.42125. Epub 2014 Apr 17.
5
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.C3 缺陷型 Her2/neu 转基因小鼠中自发性乳腺癌的早期发生和增强生长。
Oncoimmunology. 2013 Sep 1;2(9):e26137. doi: 10.4161/onci.26137. Epub 2013 Sep 12.
6
Research on stress-induced apoptosis of natural killer cells and the alteration of their killing activity in mouse liver.研究应激诱导的自然杀伤细胞凋亡及其在小鼠肝脏中杀伤活性的改变。
World J Gastroenterol. 2013 Oct 7;19(37):6258-64. doi: 10.3748/wjg.v19.i37.6258.
7
Histamine modulates microglia function.组胺调节小胶质细胞功能。
J Neuroinflammation. 2012 May 8;9:90. doi: 10.1186/1742-2094-9-90.
8
Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells.神经肽 Y 抑制小胶质细胞中白细胞介素-1β诱导的吞噬作用。
J Neuroinflammation. 2011 Dec 2;8:169. doi: 10.1186/1742-2094-8-169.
9
Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia.神经肽 Y 调节小胶质细胞中白细胞介素-1β(IL-1β)诱导的一氧化氮产生。
J Biol Chem. 2010 Dec 31;285(53):41921-34. doi: 10.1074/jbc.M110.164020. Epub 2010 Oct 19.
10
Naive mouse macrophages become activated following recognition of L5178Y lymphoma cells via concurrent ligation of CD40, NKG2D, and CD18 molecules.幼稚小鼠巨噬细胞在通过同时连接CD40、NKG2D和CD18分子识别L5178Y淋巴瘤细胞后被激活。
J Immunol. 2009 Feb 15;182(4):1940-53. doi: 10.4049/jimmunol.0800443.

本文引用的文献

1
Assays for membrane complement receptors.膜补体受体检测
Curr Protoc Immunol. 2001 May;Chapter 13:13.4.1-13.4.18. doi: 10.1002/0471142735.im1304s10.
2
NK cell receptors.自然杀伤细胞受体
Annu Rev Immunol. 1998;16:359-93. doi: 10.1146/annurev.immunol.16.1.359.
3
Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy.自然杀伤细胞系可杀伤自体β2-微球蛋白缺陷的黑色素瘤细胞:对癌症免疫治疗的启示。
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13140-5. doi: 10.1073/pnas.94.24.13140.
4
Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).通过天然存在的肿瘤细胞结合的iC3b和β-葡聚糖致敏的CR3(CD11b/CD18)将自然杀伤细胞靶向至乳腺癌
J Immunol. 1997 Jul 15;159(2):599-605.
5
A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.替代途径补体激活的一种新机制解释了C3片段在表达CR2的同源细胞上的沉积。
J Immunol. 1997 Jun 1;158(11):5455-63.
6
Emerging paradigms of integrin ligand binding and activation.整合素配体结合与激活的新兴模式。
Kidney Int. 1997 May;51(5):1454-62. doi: 10.1038/ki.1997.199.
7
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.Lck和SHP-1与自然杀伤细胞上的MHC识别受体的顺序参与抑制了FcR启动的酪氨酸激酶激活。
Immunity. 1996 Dec;5(6):629-38. doi: 10.1016/s1074-7613(00)80276-9.
8
Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.参与MHC I类识别的人类自然杀伤细胞受体是CD94和NKG2亚基的二硫键连接的异二聚体。
J Immunol. 1996 Dec 1;157(11):4741-5.
9
MHC class I-dependent and -independent NK cell specificity.
Chem Immunol. 1996;64:1-18.
10
The molecular basis of natural killer (NK) cell recognition and function.自然杀伤(NK)细胞识别与功能的分子基础。
J Clin Immunol. 1996 Sep;16(5):243-53. doi: 10.1007/BF01541388.